![1]()
News
FDA approves Doptelet for liver disease patients undergoing procedures
May 22, 2018
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure.
![1]()
News
Design limitations may have compromised DVT intervention trial
May 14, 2018
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
![1]()
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
May 4, 2018
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
![1]()
News
Does warfarin cause acute kidney injury?
May 2, 2018
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
![1]()
News
Impaired kidney function no problem for dabigatran reversal
April 23, 2018
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
![1]()
News
VTE risk after bariatric surgery should be assessed
April 22, 2018
SEATTLE – Thromboelastometry can play a role in identifying bariatric surgery patients at risk for VTE.
![1]()
News
Common infections are potent risk factor for MI, stroke
April 13, 2018
ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.
![1]()
News
The ‘holy grail’ of thrombosis prevention
April 13, 2018
SAN DIEGO – One expert says it’s the ability to determine the risk of recurrence with or without continuation of anticoagulant treatment.
![1]()
News
Patients presenting with saddle pulmonary emboli (PE) versus nonsaddle PE have no mortality difference but have an increased risk for decompensation
April 11, 2018
Do saddle pulmonary embolisms have worse outcomes compared to nonsaddle pulmonary embolisms?
![1]()
News
Using data to drive quality improvement projects
April 11, 2018
Attendees will learn how to develop balanced metrics for quality improvement projects, understand distinctions between quality improvement and traditional research projects, and identify how different measures of the same data can tell vastly different stories.
